首页> 美国卫生研究院文献>SpringerPlus >Life-threatening cardiac episode in a Polish patient carrying contiguous gene microdeletion of the TBX5 and the TBX3 genes
【2h】

Life-threatening cardiac episode in a Polish patient carrying contiguous gene microdeletion of the TBX5 and the TBX3 genes

机译:波兰患者携带TBX5和TBX3基因的连续基因微缺失危及生命

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Holt–Oram syndrome (HOS) features radial ray hypoplasia, heart defect and cardiac conduction impairment. Ulnar-mammary syndrome (UMS) characterizes congenital defects of the ulnar side of the upper limbs, underdevelopment of apocrine glands including hypoplasia and the dysfunction of mammary glands, hypogonadism and obesity. Inheritance of both conditions is autosomal dominant, mutations or deletions are found in the TBX5 and TBX3 gene, respectively. The Polish patient presented short stature, obesity, congenital malformation of the radial and ulnar side of the upper limbs, heart block, hypogonadism and dysmorphic features. At the age of 13 years he lost consciousness developing respiratory insufficiency caused by bradycardia in the course of sudden atrioventricular third degree heart block requiring immediate implantation of pace maker-defibrillator device. Microdeletion of the 12q24.21 was identified using array CGH method. This region includes contiguous genes the TBX5, TBX3, and part of RBM19. The patient initially diagnosed as having HOS, was found to present the UMS features as well. Array CGH method should be applied in patients suspected of HOS or UMS, especially when sequencing of TBX5 or TBX3 genes fails to identify causative mutation.
机译:Holt-Oram综合征(HOS)表现为放射线发育不全,心脏缺陷和心脏传导障碍。尺骨乳腺综合征(UMS)的特征是上肢尺侧的先天性缺陷,顶泌腺发育不全,包括发育不全和乳腺功能不全,性腺功能减退和肥胖。两种情况的遗传都是常染色体显性遗传,分别在TBX5和TBX3基因中发现突变或缺失。波兰患者表现出身材矮小,肥胖,先天性radial骨和尺侧畸形,心脏传导阻滞,性腺功能低下和畸形。在13岁的时候,他因突然的房室三度心脏传导阻滞而需要立即植入起搏器-除颤器装置,使他失去了意识,发展了由心动过缓引起的呼吸功能不全。使用阵列CGH方法鉴定了12q24.21的微缺失。该区域包括连续基因TBX5,TBX3和RBM19的一部分。最初被诊断为患有HOS的患者也被发现具有UMS特征。阵列CGH方法应用于怀疑有HOS或UMS的患者,尤其是当TBX5或TBX3基因的测序无法识别出致病突变时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号